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The effect of housing conditions on lipopolysaccharide-induced depressive-like behaviour in 
mice 
Robin A. Wickens, Luc Ver Donck1, Amanda B. Mackenzie & Sarah J. Bailey 
Pharmacy & Pharmacology, University of Bath 
1Department of Neuroscience, Janssen Research & Development 
Inflammation is thought to play a key role in the pathology of depression. Acute administration of 
lipopolysaccharide (LPS) is often used to assess the role of inflammation in depressive-like behaviours, 
such as the forced swim test (FST), in mice (O’Connor et al. 2009. Mol. Psychiatry. 14(5), 511-522). We 
have previously shown that acute LPS failed to induce a depressive-like behaviour in the FST (Wickens et 
al. 2014. J. Phsychopharmacol. 28(8), A107). Baseline depressive-like behaviour is influenced by 
environmental factors, including lighting and housing conditions (Bogdanova et al. 2013. Physiol. Behav. 
118, 227-239). Here, we have investigated the influence of the light cycle and group/individual housing 
on LPS-induced depressive-like behaviour in mice. 
Adult male C57BL/6J mice (10-14 weeks, Charles River) were randomly assigned to LPS or control groups 
(n=9-15/group). Mice were housed individually or in groups of 3-4 under a normal (lights on: 06:00) or 
reverse (lights on: 18:00) 12-hour light cycle. LPS (0.415 or 0.83mg/kg, i.p.) or saline was injected before 
being tested in the open field test (OFT) at +6 or +24 hours to assess sickness and the FST at +24 hours 
to assess depressive-like behaviour. Immobility in the FST was manually scored for 6 minutes. Distance 
travelled in the OFT was analyzed using automated video analysis. Data were analysed using one-way 
ANOVA followed by Dunnett posthoc test. 
Reduced locomotion was seen 6 hours after LPS administration in all housing conditions, including 
‘group-housed/light-phase’ (F(2,33)=49.82, P<0.001), ‘individual-housed/light-phase’ (F(2,27)=70.48, 
P<0.001), ‘group-housed/dark-phase’ (F(2,40)=78.56, P<0.001) and ‘individual-housed/dark-phase’ 
(F(2,33)=97.65, P<0.001). LPS had a significant effect on immobility 24 hours after LPS administration in 
‘group-housed/light-phase’ mice (F(2,29)=5.582, P<0.0089), with 0.415mg/kg LPS inducing a significant 
increase in immobility (P<0.05), but had no effect in all other housing and lighting conditions. Reduced 
locomotion was still present in the OFT at 24 hours after LPS (F(2,49)=8.621, P<0.001). 
Whilst sickness behaviour, as interpreted by reduced locomotion in the OFT, was observed in all LPS-
treated groups, depressive-like behaviour in the FST was only observed in one group: group-
housed/light-phase, 0.415mg/kg LPS. This finding suggests that the depressive response to LPS in the 
FST is sensitive to the housing conditions, along with the dose of LPS used. However, reduced 
locomotion was observed at 24 hours, indicating the presence of sickness, which is a confounding factor 
for depressive-like behaviour in the FST observed at 24 hours. 
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